For research use only. Not for therapeutic Use.
ABT-224 (CAT: I000759) is a selective 5-HT4 receptor agonist, investigated for its potential therapeutic application in treating constipation. By activating 5-HT4 receptors in the gastrointestinal tract, it enhances peristalsis, promotes intestinal motility, and facilitates bowel movements. This targeted mechanism positions ABT-224 as a promising candidate for addressing gastrointestinal disorders characterized by reduced motility. ABT-224 is particularly significant in gastrointestinal research, where it supports the exploration of serotonergic pathways and the development of effective treatments for constipation and related motility disorders.
Catalog Number | I000759 |
CAS Number | 287399-47-7 |
Synonyms | ABT-224; AU-224; ABT224; AU224; ABT 224; AU 224;piperidin-1-yl(quinoxalin-6-yl)methanone |
Molecular Formula | C14H15N3O |
Purity | ≥95% |
Target | 5-HT4 agonist |
Solubility | Soluble in DMSO |
Storage | 0 - 4°Cfor short term (days to weeks), or -20 °C for long term (months). |
IUPAC Name | butyl 2-[4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]piperidin-1-yl]acetate |
InChI | InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2 |
InChIKey | ANDGGVOPIJEHOF-UHFFFAOYSA-N |
SMILES | O=C(N1CCCCC1)C2=CC=C3N=CC=NC3=C2 |